Company intelligence / Profile preview

Rigaku

Tokyo, Japan

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

Rigaku provides advanced analytical instruments supporting life science research, including crystallography, molecular imaging, and Raman spectroscopy. Their technologies enable protein and small molecule structural determination, aiding drug discovery and biopharma R&D. Recent launches like MoleQlyze allow the study of biological macromolecules in solution without crystallization, bringing new capabilities to monoclonal antibody and advanced drug pipeline development[2][1][5][7].

Modalities: DeviceDrug discovery research instrumentation
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Rigaku.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rigaku.

Explore the full profile